Ridogrel structure
|
Common Name | Ridogrel | ||
---|---|---|---|---|
CAS Number | 110140-89-1 | Molecular Weight | 366.33400 | |
Density | 1.26g/cm3 | Boiling Point | 495.2ºC at 760mmHg | |
Molecular Formula | C18H17F3N2O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 253.3ºC |
Use of RidogrelRidogrel (R 68070) is an orally active combined thromboxane A2 synthetase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor blocker. Ridogrel is potent antiplatelet agent. Anti-inflammatory activities[1][2][3]. |
Name | Pentanoic acid, 5-[[(E)-[3-pyridinyl[3-(trifluoromethyl)phenyl]methylene]amino]oxy] |
---|---|
Synonym | More Synonyms |
Description | Ridogrel (R 68070) is an orally active combined thromboxane A2 synthetase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor blocker. Ridogrel is potent antiplatelet agent. Anti-inflammatory activities[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | In rats, R 68 070 (1.25 mg/kg orally, -2 h) singly prolongs tail bleeding times as much as a combination of TXA2 synthetase inhibition (dazoxiben 10 mg/kg) and TXA2/prostaglandin endoperoxide receptor blockade (BM 13177 40 mg/kg). In dogs, the compound reduces coronary thrombosis induced by electrical damage (1.25 mg/kg i.v.) and prevents the evolution of occlusion/reperfusion-induced arrhythmias into ventricular fibrillation (2.5 mg/kg i.v.)[2. |
References |
Density | 1.26g/cm3 |
---|---|
Boiling Point | 495.2ºC at 760mmHg |
Molecular Formula | C18H17F3N2O3 |
Molecular Weight | 366.33400 |
Flash Point | 253.3ºC |
Exact Mass | 366.11900 |
PSA | 71.78000 |
LogP | 4.12430 |
Vapour Pressure | 1.26E-10mmHg at 25°C |
Index of Refraction | 1.531 |
~41% Ridogrel CAS#:110140-89-1 |
Literature: US4746671 A1, ; |
Precursor 2 | |
---|---|
DownStream 0 |
ridogrel |